| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.25 | 0.1 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.25 | 0.1 |